Background
==========

Gonadotrophins are routinely used for follicular stimulation in ovarian induction (OI) and assisted reproduction techniques (ART). Follicle-stimulating hormone (FSH) and HMG (human menopausal gonadotrophin) are used during OI and ART to stimulate the growth and recruitment of immature follicles in the ovary \[[@B1],[@B2]\]. FSH is currently available in two preparations: urinary FSH (u-FSH) and recombinant FSH (r-FSH). HMG and u-FSH are extracted from the urine of postmenopausal women, whereas r-FSH, which became available in 1996, is produced using recombinant DNA technology.

Daily injections of recombinant peptides are required for several conditions such as growth hormone for growth deficiencies in children. Injections that are required on a long-term, regular basis must be quick, simple and as pain free as possible to ensure patients comply with treatment \[[@B3]\]. During treatment for OI and ART, gonadotrophins have to be injected daily for an average of 10 days and are often reconstituted from freeze-dried peptides. Traditionally, HMG has been administered as an intramuscular injection. However, the development of the higher purity FSH preparations has enabled subcutaneous injections to be used. Advances in FSH formulations have been accompanied by progress in the devices available for the delivery of the peptides. The subcutaneous administration systems that have evolved for r-FSH generally enable self-administration at home and have led to improvements in patient satisfaction and quality of life \[[@B4]-[@B10]\].

It is well established that treatment outcomes can be affected by patient compliance, and that compliance is related to treatment choice and method of administration. For example, therapies that are easier to administer and cause less injection site pain are associated with higher rates of compliance than those that are difficult to administer and cause pain \[[@B4],[@B7],[@B10],[@B11]\]. It has been demonstrated previously that patients, who receive subcutaneous injections for IVF, reported experiencing less pain than those who receive intramuscular injections \[[@B12]\]. Moreover, it has been documented that patients can make errors in the reconstitution of freeze-dried peptides for self-administration at home, and pregnancy rates are higher in patients who prepare and administer injections correctly \[[@B10]\].

The follitropin-alpha (Gonal-f) filled-by mass (FbM) prefilled pen (Merck Serono SA, Geneva, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany) is a ready-to-use disposable injection delivery device. The pen contains premixed follitropin alfa filled-by-mass, which provides more accurate and consistent dosing than r-FSH filled-by-bioassay \[[@B8]\]. Routine use of follitropin-alpha in ART was well accepted by patients participating in a German observational study; in addition, study patients required less training to use follitropin-alpha pens compared with vials or ampoules \[[@B13]\]. More importantly from a compliance point of view, patients preferred the prefilled pen compared with another loadable device (a reusable pen with loadable cartridges) \[[@B13]\]. Results from two other studies suggest that the follitropin-alpha prefilled pen had higher patient and nurse acceptance than the follitropin-beta pen (supplied in glass cartridges to be used with a pen injector; Puregon; Organon, Roseland, NJ, USA) \[[@B14]\]. Another survey found that more patients preferred the follitropin-alpha prefilled pen to the follitropin-beta cartridge pen or urofollitropin (Ferring Pharmaceuticals, Suffern, NY, USA) administered with a needle-free reconstitution device and conventional syringe. Additionally, patients stated that the ease of use, dosing mechanism and reduced potential for dosing errors were the factors that they found most important \[[@B15]\].

The current study was designed to evaluate overall patient satisfaction, ease of learning and use, and injection site pain associated with the follitropin-alpha (FbM) prefilled pen. A secondary comparison was made with other systems of gonadotrophin administration. The study---which involved over 650 patients treated at 23 Japanese fertility centres---was the largest study of patient preference to be performed in Japan.

Methods
=======

Study design
------------

This was a questionnaire-based survey conducted in 23 clinics certified by the Japanese Institution for Standardising Assisted Reproductive Technology (JISART). JISART aims to achieve high standards of practice in fertility treatments by implementing a quality management system, with the ultimate goal of improving the quality of patient care.

Patients
--------

Women receiving OI or ART fertility treatment with the follitropin-alpha (FbM) prefilled pen in their current treatment cycle were eligible for inclusion in the study. No further inclusion or exclusion criteria were used. Patients from 23 JISART-certified clinics were recruited into the study over 14 months from October 2009 to December 2010, with a target recruitment number of 650.

Assessment
----------

Patients undergoing treatment with the follitropin-alpha (FbM) prefilled pen were asked to complete a questionnaire to assess their ease of learning and use, injection site pain and overall satisfaction. The first part of the questionnaire was completed after appropriate instruction was given for the patients to learn how to use the device and included 7 multiple-choice questions that were associated with how easy patients found it to learn to use the follitropin-alpha (FbM) prefilled pen. The second part of the questionnaire, completed at the end of the treatment, consisted of 10 questions that assessed how easy patients found the pen to use, how painful patients found the pen and the patients' overall satisfaction with the pen. If a patient had experience in previous treatment cycles of using formulations of FSH other than follitropin-alpha, with different methods of administration, she was asked to compare the follitropin-alpha (FbM) prefilled pen with the previous therapy. This section of the questionnaire enabled comparison of the follitropin-alpha (FbM) prefilled pen with other systems of gonadotrophin administration. The scoring system for the questionnaire ranged from 1 to 10 for ease of learning and use, as well as overall satisfaction with a score of 10 reflecting the most positive experience. The scoring for injection site pain also ranged from 1 to 10 on a numerical rating scale, with 10 being the most painful experience.

Reporting methods
-----------------

Patient responses were calculated as a percentage of the population who responded to each question. Studies that use patient questionnaires to gather information invariably have some data missing from the completed forms. In these cases, the responses were not included in the final analysis.

Results
=======

Patient and treatment characteristics
-------------------------------------

A total of 663 women who were prescribed follitropin-alpha (FbM) prefilled pen (OI = 39.4%, n = 261/663; ART = 60.6%, n = 402/663) at 23 JISART-certified clinics were recruited into the study. The majority of participating women self-administered their injections (68.5%; n = 454/663) or partly self-administered their injections (27.9%; n = 185/663).

Ease of learning
----------------

A total of 663 women who were receiving treatment with the follitropin-alpha (FbM) prefilled pen in their current treatment cycle participated in the questionnaire-based study. Patients were asked a series of questions to assess how easy it was to learn to use the follitropin-alpha (FbM) prefilled pen and a full list of questions and tallied responses are shown in Table [1](#T1){ref-type="table"}.

###### 

Ease of learning\*

  **Question**                                                                                                                                             **Possible answers**            **Patient response (n)**   **Patient response (%)**   **Total no. patients who responded to question**  
  ---------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------- -------------------------- -------------------------- -------------------------------------------------- -----
  Were the instructions for administering the follitropin-alpha pen easy to understand?                                                                            Yes                               546                        83.0                                   658                         
                                                                                                                                                                    OK                               106                        16.1                                   658                         
                                                                                                                                                                    No                                6                         0.9                                    658                         
                                                                                                                                                                   N/A                                5                                                                                            
  Which tools did you use to learn how to use the follitropin-alpha pen and how useful were they?                                                 Hands-on demonstration by nurse/doctor         Very useful                    582                                    91.5                         636
                                                                                                                                                                                                    Useful                       52                                    8.2                          636
                                                                                                                                                                                                  Not useful                     2                                     0.3                          636
                                                                                                                                                                                                     N/A                         27                                                                   
                                                                                                                                                                 Leaflet                         Very useful                    421                                    71.1                         592
                                                                                                                                                                                                    Useful                      161                                    27.2                         592
                                                                                                                                                                                                  Not useful                     10                                    1.7                          592
                                                                                                                                                                                                     N/A                         71                                                                   
                                                                                                                                                                   DVD                           Very useful                    160                                    47.3                         338
                                                                                                                                                                                                    Useful                      135                                    39.9                         338
                                                                                                                                                                                                  Not useful                     43                                    12.7                         338
                                                                                                                                                                                                     N/A                        325                                                                   
                                                                                                                                                                   Web                           Very useful                     18                                    26.1                         69
                                                                                                                                                                                                    Useful                       21                                    30.4                         69
                                                                                                                                                                                                  Not useful                     30                                    43.5                         69
                                                                                                                                                                                                     N/A                        594                                                                   
  Which of the tools did you find was the most useful in learning how to use the follitropin-alpha pen?                                           Hands-on demonstration by nurse/doctor             497                        80.0                                   621                         
                                                                                                                                                                 Leaflet                              89                        14.3                                   621                         
                                                                                                                                                                   DVD                                35                        5.6                                    621                         
                                                                                                                                                                   Web                                0                         0.0                                    621                         
                                                                                                                                                                   N/A                                42                                                                                           
  How easy was it for you to understand how to use the follitropin-alpha pen?                                                                               1 (very difficult)                        3                         0.5                                    658                         
                                                                                                                                                                    2                                 4                         0.6                                    658                         
                                                                                                                                                                    3                                 11                        1.7                                    658                         
                                                                                                                                                                    4                                 5                         0.8                                    658                         
                                                                                                                                                                    5                                 26                        4.0                                    658                         
                                                                                                                                                                    6                                 21                        3.2                                    658                         
                                                                                                                                                                    7                                 49                        7.4                                    658                         
                                                                                                                                                                    8                                152                        23.1                                   658                         
                                                                                                                                                                    9                                128                        19.5                                   658                         
                                                                                                                                                              10 (very easy)                         259                        39.4                                   658                         
                                                                                                                                                                   N/A                                5                                                                                            
  Based on your experience of learning, would you ecommend the follitropin-alpha pen to another woman who was considering fertility treatment?                     Yes                               611                        94.9                                   644                         
                                                                                                                                                                    No                                33                        5.1                                    644                         
                                                                                                                                                                   N/A                                19                                                                                           
  Have you used any of the following medications in the past? If yes, please select the medication that you most recently used^†^                             Follistim pen                          130                        40.9                                   318                         
                                                                                                                                                              Follistim vial                          53                        16.7                                   318                         
                                                                                                                                                                   hMG                               119                        37.4                                   318                         
                                                                                                                                                                 Gonapure                             6                         1.9                                    318                         
                                                                                                                                                                Folyrmon P                            10                        3.1                                    318                         
                                                                                                                                                          N/A or no previous use                     348                                                                                           
  Which treatment did you find to be the easiest to use: the follitropin-alpha pen or a previous treatment medication?                                    Follitropin-alpha pen                      232                        75.1                                   309                         
                                                                                                                                                             Same ease of use                         70                        22.7                                   309                         
                                                                                                                                                              Other product                           7                         2.3                                    309                         
                                                                                                                                                              N/A or no use                          354                                                                                           

\*Patients were asked a series of questions to assess how easy it was to learn to use the follitropin-alpha (FbM) prefilled pen. N/A = patient did not answer the question. ^†^ Includes multiple answers.

The majority of patients surveyed (83.0%; n = 546/658) found the instructions for administering follitropin-alpha with the prefilled pen easy to understand and patients gave an average score of 8.54 out of 10 for ease of learning (1 = difficult to understand; 10 = easy to understand). Several tools were employed to teach patients how to use the follitropin-alpha (FbM) prefilled pen, including doctor/nurse's guidance, a printed leaflet, a DVD video and a website page. Women found doctor/nurse's guidance (91.5%; n = 582/636), a printed leaflet (71.1%; n = 421/592) and DVD (47.3%; n = 160/338) were the most effective learning tools, whereas the majority of patients did not use, or did not confirm whether they had used, the website page as a training aid (89.6%; n = 594/663) or did not find it useful (43.5%; n = 30/69). Overall, 80.0% (n = 497/621) of patients found that a hands-on demonstration by a nurse or doctor was the most useful training tool, 14.3% (n = 89/621) found a printed leaflet was the most useful tool and 5.6% (n = 35/621) found a DVD the most useful, whereas no women found the website page to be the most useful tool.

Forty-eight percent of patients in the study had previous experience with gonadotropin medications, other than follitropin-alpha, for the treatment of infertility. These were the follitropin-beta pen (rFSH, Follistim cartridge-type pen; Organon, Roseland, NJ, USA; 40.9%; n = 130/318), hMG (vial, ampoule and syringe; 37.4%; n = 119/318), follitropin-beta vial (rFSH, Follistim vial; Organon, Roseland, NJ, USA; 16.7%; n = 53/318), Folyrmon P (uFSH, ampoule and syringe; Fuji Seiyaku Kogyo, Chuo-ku, Tokyo, Japan; 3.1%; n = 10/318) and Gonapure (uFSH, ampoule and syringe, ASKA Pharmaceutical, Tokyo, Japan; 1.9%; n = 6/318). When questioned if they found the follitropin-alpha (FbM) prefilled pen easier to learn to use than a previous treatment, 75.1% (n = 232/309) of patients stated that follitropin-alpha was easier to use, 22.7% (n = 70/309) thought there was no difference in ease of use between treatments and 2.3% (n = 7/309) believed their previous treatment was easier to use. When patients were questioned as to whether they would recommend the follitropin-alpha (FbM) prefilled pen to another woman considering fertility treatment based on how easy they found it to learn to use, the majority of patients said they would recommend follitropin-alpha (94.9%; n = 611/644).

Ease of use and injection site pain
-----------------------------------

Patients were also asked a series of questions to assess how easy they found the follitropin-alpha (FbM) prefilled pen to use and their overall satisfaction with the device (Table [2](#T2){ref-type="table"}**)**. Patients gave an average score of 8.65 out of 10 for ease of use (1 = difficult to use; 10 = easy to use). Almost all of the patients responded that the follitropin-alpha (FbM) prefilled pen was very easy to use (78.9%; n = 514/651) or that they had little difficulty in self-injection (19.2%; n = 125/651) (Figure [1](#F1){ref-type="fig"}), and 99.1% (n = 639/645) of the women were able to administer some or all of their own injections with the follitropin-alpha (FbM) prefilled pen. Seventy-five percent (232/309) of women who had prior experience of other treatments for infertility found injection with the follitropin-alpha (FbM) prefilled pen easier to learn to use than the prior therapy.

###### 

Ease of use and level of satisfaction\*

  **Question**                                                                                                                                                      **Possible answers**                               **Patient response (n)**   **Patient response (%)**   **Total no. patients who responded to question**
  ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------ -------------------------- -------------------------- --------------------------------------------------
  How easy did you find the self-injection of the follitropin-alpha pen?                                                                                                 Very easy                                               514                        79.0                                   651
                                                                                                                                                                     A little difficult                                          125                        19.2                                   651
                                                                                                                                                                         Difficult                                                11                        1.7                                    651
                                                                                                                                                                       Very difficult                                             1                         0.2                                    651
                                                                                                                                                                            N/A                                                   12                                                                 
  How easy was it for you to use the follitropin-alpha pen?                                                                                                         1 ( very difficult)                                           5                         0.8                                    651
                                                                                                                                                                             2                                                    4                         0.6                                    651
                                                                                                                                                                             3                                                    7                         1.1                                    651
                                                                                                                                                                             4                                                    8                         1.2                                    651
                                                                                                                                                                             5                                                    24                        3.7                                    651
                                                                                                                                                                             6                                                    7                         1.1                                    651
                                                                                                                                                                             7                                                    41                        6.3                                    651
                                                                                                                                                                             8                                                   129                        19.8                                   651
                                                                                                                                                                             9                                                   174                        26.7                                   651
                                                                                                                                                                       10 (very easy)                                            252                        38.7                                   651
  Did you administer the injections yourself during this treatment cycle?                                                                                             Yes, completely                                            454                        70.4                                   645
                                                                                                                                                                    Yes, some injections                                         185                        28.7                                   645
                                                                                                                                                                             No                                                   6                         0.9                                    645
                                                                                                                                                                            N/A                                                   18                                                                 
  Did you use the follitropin-alpha pen (self-injection) outside the home?                                                                                 Yes, I have injected outside the home                                 116                        17.8                                   651
                                                                                                                                                        No, all injections were administered at home                             535                        82.2                                   651
                                                                                                                                                                            N/A                                                   12                                                                 
                                                                                                                                        *If Yes, how convenient was it to carry the follitropin-alpha pen with you?*                                                        
                                                                                                                                                                         Very good                                                49                        43.0                                   114
                                                                                                                                                                            Good                                                  60                        52.6                                   114
                                                                                                                                                                            Bad                                                   5                         4.4                                    114
  How confident did you feel that you accurately administered your daily dose using the follitropin-alpha pen during this treatment?                                   Very confident                                            283                        43.8                                   646
                                                                                                                                                                     Somewhat confident                                          357                        55.3                                   646
                                                                                                                                                                    Not at all confident                                          6                         0.9                                    646
                                                                                                                                                                            N/A                                                   17                                                                 
  How painful was the injection with the follitropin-alpha pen                                                                                                          0 (no pain)                                              139                        21.2                                   657
                                                                                                                                                                             1                                                   236                        35.9                                   657
                                                                                                                                                                             2                                                   123                        18.7                                   657
                                                                                                                                                                             3                                                    77                        11.7                                   657
                                                                                                                                                                             4                                                    21                        3.2                                    657
                                                                                                                                                                             5                                                    36                        5.5                                    657
                                                                                                                                                                             6                                                    13                        2.0                                    657
                                                                                                                                                                             7                                                    5                         0.8                                    657
                                                                                                                                                                             8                                                    4                         0.6                                    657
                                                                                                                                                                             9                                                    2                         0.3                                    657
                                                                                                                                                                       10 (most pain)                                             1                         0.2                                    657
  Which was less painful; follitropin-alpha pen or other product?                                                                                                  Follitropin-alpha pen                                         347                        89.0                                   390
                                                                                                                                                                            Same                                                  39                        10.0                                   390
                                                                                                                                                                       Other product                                              4                         1.0                                    390
                                                                                                                                                               N/A or No use of other product                                    273                                                                 
  Overall, how satisfied are you with the follitropin-alpha pen                                                                                                          Satisfied                                               521                        80.2                                   650
                                                                                                                                                             Neither satisfies or not satisfied                                  124                        19.1                                   650
                                                                                                                                                                       Not satisfied                                              5                         0.8                                    650
                                                                                                                                                                            N/A                                                   13                                                                 
  How would you rate the overall level of satisfaction when using the follitropin-alpha pen?                                                                      1 (not satisfied at all)                                        4                         0.6                                    651
                                                                                                                                                                             2                                                    2                         0.3                                    651
                                                                                                                                                                             3                                                    4                         0.6                                    651
                                                                                                                                                                             4                                                    5                         0.8                                    651
                                                                                                                                                                             5                                                    34                        5.2                                    651
                                                                                                                                                                             6                                                    18                        2.8                                    651
                                                                                                                                                                             7                                                    42                        6.5                                    651
                                                                                                                                                                             8                                                   141                        21.7                                   651
                                                                                                                                                                             9                                                   153                        23.5                                   651
                                                                                                                                                                    10 (very satisfied)                                          248                        38.1                                   651
  Based on your experience, would you recommend follitropin-alpha pen to another woman considering fertility treatment?                                                     Yes                                                  596                        93.9                                   635
                                                                                                                                                                             No                                                   39                        6.1                                    635
                                                                                                                                                                            N/A                                                   28                                                                 

\*Patients were asked a series of questions to assess how easy it was to use the follitropin-alpha (FbM) prefilled pen and to assess overall levels of satisfaction with the pen. N/A = patient did not answer the question.

![**Ease of use.** Pie chart shows the percentage of patients responding by category to the question 'How easy was it for you to use the follitropin-alpha pen?' (n=663).](1477-7827-10-93-1){#F1}

When questioned how painful they found injection with the follitropin-alpha (FbM) prefilled pen, almost a quarter of respondents said they experienced no pain (score of 0; 20.9%; n = 137/657) and a little pain was reported by the majority of patients (score of between 0.5 and 4; 69.9%; n = 459/657) (Figure [2](#F2){ref-type="fig"}). Among the patients who had prior experience of other treatments for infertility, 89.0% (n = 347/390) found follitropin-alpha to be less painful to use than the other treatment.

![**Injection site pain during use.** Pie chart shows the percentage of patients responding by category to the question 'How painful was the injection with the Gonal-f pen?' (n=663).](1477-7827-10-93-2){#F2}

Overall patient satisfaction
----------------------------

The majority (80.2%; n = 521/650) of women reported being satisfied with their treatment experience using the follitropin-alpha (FbM) prefilled pen compared with 19.1% (n = 124/650) who were neither satisfied nor dissatisfied and 0.7% (n = 5/650) who were not satisfied (Figure [3](#F3){ref-type="fig"}). The follitropin-alpha (FbM) prefilled pen received an average score of 8.6 out of 10 (1 = not satisfied; 10 = very satisfied). Nearly all (93.9%; n = 596/635) of survey respondents said they would recommend using the follitropin-alpha (FbM) prefilled pen to another woman considering fertility treatment. Patients who found the follitropin-alpha (FbM) prefilled pen easy to learn and use demonstrated the highest overall satisfaction (Figure [4](#F4){ref-type="fig"}). However, there was no direct correlation between ease of learning and use, and overall satisfaction. Additionally, patients who experienced little pain at the injection site when using the follitropin-alpha (FbM) prefilled pen had higher overall satisfaction than patients who experienced pain at the injection site (Figure [5](#F5){ref-type="fig"}).

![**Level of patient satisfaction.** Pie chart shows the percentage of patients responding by category to the question 'How would you rate the overall level of satisfaction when using the follitropin-alpha pen?' (n=663).](1477-7827-10-93-3){#F3}

![**Ease of learning, ease of use and overall satisfaction.** Patients were asked to rate the ease of learning, ease of use and overall satisfaction with the follitropin-alpha pen on a scale of 1 to 10 (n = 663).](1477-7827-10-93-4){#F4}

![**Injection site pain and overall satisfaction.** Patients were asked to rate the injection site pain and overall satisfaction with the follitropin-alpha (FbM) pen on a scale of 1 to 10 (n = 663).](1477-7827-10-93-5){#F5}

Discussion
==========

The results from this questionnaire-based survey---which involved 663 women and was the largest of its type to be performed in Japan---show that the majority of patients found the follitropin-alpha pen easy to learn, to use and to administer with minimal pain experienced at the injection site. Higher overall patient satisfaction appeared to be associated with higher scores for ease of learning and use, as well as less pain at the injection site, although no direct correlation between these factors was found. Seventy-five percent (232/309) of patients who had experience of other treatments for infertility found the follitropin-alpha (FbM) prefilled pen the easiest product to use and almost all would recommend the use of the follitropin-alpha pen to other women. These results are comparable to those from two other studies reported in a single publication by Porter et al. \[[@B14]\]. The first was a 2-year observational study conducted in Germany, which found that patients favoured treatment with the follitropin-alpha (FbM) prefilled pen over the follitropin-beta pen due to faster preparation, greater confidence in dosing accuracy and the need for fewer dose adjustments \[[@B14]\]. In the second study, conducted in Australia, patients again favoured the follitropin-alpha (FbM) prefilled pen over the follitropin-beta pen for the same reasons. Additionally, patients experienced less injection site pain with the follitropin-alpha (FbM) prefilled pen than with the follitropin-beta pen \[[@B14]\]. A larger questionnaire-based study of 5328 patients undergoing ART in Germany reported that the routine use of the follitropin-alpha (FbM) prefilled pen was well accepted by patients \[[@B13]\]. In this study, patients found the follitropin-alpha (FbM) prefilled pen easier to learn to use than other injection methods and reported it as their preferred method of FSH administration \[[@B13]\].

The current study included an exploration of patients' views on the different tools provided to teach them how to use the follitropin-alpha (FbM) prefilled pen. Surprisingly, web-based training was not widely utilised and was associated with lower overall satisfaction than the other training tools. Patients found hands-on demonstration by a doctor or nurse to be the most useful tool for learning how to use the follitropin-alpha (FbM) prefilled pen. When a healthcare professional demonstrates how to perform the injection, patients have the chance to ask any questions they may have on correct administration and what they should do if they encounter any problems. Asking a doctor or nurse can provide patients with the reassurance that they need to correctly administer the treatment at home by themselves. Interestingly, nurses have also reported very high levels of satisfaction with their experiences of teaching patients to use the follitropin-alpha pen \[[@B14]\].

One of the advantages of a ready-to-use device is that it reduces the chances of a reconstitution error occurring. The follitropin-alpha (FbM) prefilled pen lowers the possibility of both injection and dosing errors, which could potentially affect patient confidence in the device as well as the choice of device used in fertility programmes. Additionally, increased patient confidence, dosing consistency and dosing accuracy are key requirements for a drug delivery device to allow physicians to maximise the predictability of ovarian stimulation and success \[[@B10]\].

When questioned, over three quarters of the patients in the study who had previous experience of other gonadotrophin formulations and devices found the follitropin-alpha pen easier to use and reported less injection site pain than with other products. Of note, in a study of patients receiving human growth hormone injections, the five key delivery device attributes identified by patients were reliability, ease of use, lack of pain, safety in use and a small number of steps required for preparation \[[@B16]\]. The follitropin-alpha (FbM) prefilled pen encompasses all of these attributes. Also worthy of consideration is that the introduction of insulin self-injection pens for patients with diabetes led to an improvement in patient compliance and treatment outcomes, with patients reporting that they found injection pens less painful than syringes and needles \[[@B17]-[@B22]\]. It is likely that the use of injection pens for infertility treatment that cause less injection site pain than conventional syringes will have a similar positive effect on compliance. It has also been demonstrated in many therapeutic areas that increasing patient information leads to increased patient satisfaction and adherence to treatment \[[@B23]-[@B26]\].

Additionally, it has been suggested that the efficacy of ovarian stimulation regimens may improve with the use of injection pen devices compared with conventional syringes. This could be due to several factors such as increased adherence to treatment and also the correct administration and dosing of treatment. However, further evidence is required to support these claims \[[@B27]-[@B29]\].

In summary, the follitropin-alpha (FbM) prefilled pen is an easy-to-use injection device and offers reduced injection site pain compared with conventional devices. A high level of overall patient satisfaction with the follitropin-alpha (FbM) prefilled pen was documented in this study involving 23 JISART-certified fertility centres in Japan. The results of this survey are in agreement with previous findings confirming the ease of learning and use of the pen in both previously untreated patients and patients with previous experience of other fertility treatments.
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